UNSPSC 51262701: Tolazoline

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C10H12N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CHH9H12AQ3, chemically known as 4,5-dihydro-2-(phenylmethyl)-1h-imidazole but generally known as tolazoline, which bears US NIH Compound Identifier 5504. European Medicines Agency schedules Tolazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11148MIG. The term TOLAZOLINE is an International Non-Proprietary Name.

UNSPSC 51262701 Tolazoline is a Commodity code nominally identifying a single pharmaceutical product, but recent state and local solicitations tagged under this code show little activity directly aligned with tolazoline procurement. The one pharmaceutical opportunity on record — Seminole County, Florida's IFB60459723LAS posted June 30, 2026 — targets naloxone and drug deactivation systems for community health support, not tolazoline. The Texas Health and Human Services Commission's concurrent RFI HHS0017013 addresses direct-to-manufacturer prescription programs and PBM contracting strategy, a wholesale-level policy initiative rather than procurement of tolazoline or a specific pharmaceutical commodity. The mismatch between the code's nominal scope and the actual recent opportunities suggests either categorical mistagging in the source data or minimal contemporary tolazoline purchasing activity at the state and local level. Issuing bodies appearing in the recent record include a county health authority and a state human services agency, but the sample is too small and off-target to characterize the typical buyer mix for this code.

Geographic activity is limited to Florida and Texas within the recent record. The Seminole County solicitation, with a response deadline of July 26, 2026, represents a direct procurement action with defined specifications and quarterly delivery requirements; the Texas HHS RFI, closed April 3, 2026, was exploratory in nature and did not advance to a formal competitive solicitation. No other jurisdictions or recent solicitations appear in the available data. The code shows minimal relevant recent activity, and business development professionals should verify whether tolazoline procurement is currently a significant line item in their target markets before allocating resources to this code.